HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703

Philippa C Matthews, Emily Adland, Jennifer Listgarten, Alasdair Leslie, Nompumelelo Mkhwanazi, Jonathan M Carlson, Mikkel Harndahl, Anette Stryhn Buus, Rebecca P Payne, Anthony Ogwu, Kuan-Hsiang Gary Huang, John Frater, Paolo Paioni, Henrik Kloverpris, Pieter Jooste, Dominique Goedhals, Cloete van Vuuren, Dewald Steyn, Lynn Riddell, Fabian ChenGraz Luzzi, Thambiah Balachandran, Thumbi Ndung'u, Søren Buus, Mary Carrington, Roger Shapiro, David Heckerman, Philip J R Goulder

41 Citations (Scopus)

Abstract

The potential contribution of HLA-A alleles to viremic control in chronic HIV type 1 (HIV-1) infection has been relatively understudied compared with HLA-B. In these studies, we show that HLA-A*7401 is associated with favorable viremic control in extended southern African cohorts of >2100 C-clade-infected subjects. We present evidence that HLA-A*7401 operates an effect that is independent of HLA-B*5703, with which it is in linkage disequilibrium in some populations, to mediate lowered viremia. We describe a novel statistical approach to detecting additive effects between class I alleles in control of HIV-1 disease, highlighting improved viremic control in subjects with HLA-A*7401 combined with HLA-B*57. In common with HLA-B alleles that are associated with effective control of viremia, HLA-A*7401 presents highly targeted epitopes in several proteins, including Gag, Pol, Rev, and Nef, of which the Gag epitopes appear immunodominant. We identify eight novel putative HLA-A*7401-restricted epitopes, of which three have been defined to the optimal epitope. In common with HLA-B alleles linked with slow progression, viremic control through an HLA-A*7401-restricted response appears to be associated with the selection of escape mutants within Gag epitopes that reduce viral replicative capacity. These studies highlight the potentially important contribution of an HLA-A allele to immune control of HIV infection, which may have been concealed by a stronger effect mediated by an HLA-B allele with which it is in linkage disequilibrium. In addition, these studies identify a factor contributing to different HIV disease outcomes in individuals expressing HLA-B*5703.
Original languageEnglish
JournalJournal of Immunology
Volume186
Issue number10
Pages (from-to)5675-86
Number of pages12
ISSN1550-6606
DOIs
Publication statusPublished - 15 May 2011

Keywords

  • Africa
  • Alleles
  • CD4 Lymphocyte Count
  • CD8-Positive T-Lymphocytes
  • Epitopes, T-Lymphocyte
  • Female
  • Flow Cytometry
  • HIV Infections
  • HIV-1
  • HLA-A Antigens
  • HLA-B Antigens
  • Humans
  • Linkage Disequilibrium
  • Molecular Sequence Data
  • Sequence Analysis, Protein
  • Viral Load
  • Viremia
  • gag Gene Products, Human Immunodeficiency Virus
  • nef Gene Products, Human Immunodeficiency Virus
  • pol Gene Products, Human Immunodeficiency Virus
  • rev Gene Products, Human Immunodeficiency Virus

Fingerprint

Dive into the research topics of 'HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703'. Together they form a unique fingerprint.

Cite this